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Abstract
Proteins bearing a leucine-rich nuclear export signal (NES) are exported from the nucleus by the transport factor CRM1,
which forms a cooperative ternary complex with the NES-bearing cargo and with the small GTPase Ran. CRM1-mediated
export is regulated by RanBP3, a Ran-interacting nuclear protein. Unlike the related proteins RanBP1 and RanBP2, which
promote disassembly of the export complex in the cytosol, RanBP3 acts as a CRM1 cofactor, enhancing NES export by
stabilizing the export complex in the nucleus. RanBP3 also alters the cargo selectivity of CRM1, promoting recognition of the
NES of HIV-1 Rev and of other cargos while deterring recognition of the import adaptor protein Snurportin1. Here we report
the crystal structure of the Ran-binding domain (RBD) from RanBP3 and compare it to RBD structures from RanBP1 and
RanBP2 in complex with Ran and CRM1. Differences among these structures suggest why RanBP3 binds Ran with unusually
low affinity, how RanBP3 modulates the cargo selectivity of CRM1, and why RanBP3 promotes assembly rather than
disassembly of the export complex. The comparison of RBD structures thus provides an insight into the functional diversity
of Ran-binding proteins.
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Introduction
CRM1/Exportin1, a member of the importin-b/karyopherin-b
family of nuclear transport factors, is responsible for exporting
many proteins and ribonucleoproteins from the nucleus to the
cytosol [1–4]. Macromolecular cargos exported by CRM1 are
characterized by a leucine-rich nuclear export signal (NES), a
short, loosely conserved motif first discovered in HIV-1 Rev and
protein kinase A inhibitor (PKI) and subsequently identified in
over 75 cellular and viral proteins [5–7]. CRM1-mediated export
is dependent on the small GTPase Ran, whose nucleotide-bound
state is regulated by the Ran GTPase-activating protein (RanGAP)
and by the guanine nucleotide exchange factor RCC1 [8,9].
Because RCC1 is restricted to the nucleus whereas RanGAP is
excluded from this compartment, Ran is primarily bound to GTP
in the nucleus and to GDP in the cytosol – an asymmetric
distribution critical for the directionality of nuclear transport [10].
In the nucleus, CRM1 associates in a cooperative manner with
RanGTP and with the NES-bearing cargo to form a ternary
CRM1/Ran/cargo complex that translocates through the nuclear
pore complex (NPC) and subsequently dissociates in the cytosol. In
the absence of Ran, CRM1 has low binding affinity for most NES-
bearing cargos. However, CRM1 binds tightly to certain cargos,
including proteins with supraphysiological NES motifs [11,12] and
Snurportin1 (Spn1), an import adaptor for m3G-capped U
snRNPs [13]. The crystal structures of human CRM1 in binary
complex with Spn1 and in ternary complex with Ran and Spn1
revealed that CRM1 consists of 20 tandem HEAT repeats [14,15].
These approximately 50-residue motifs comprise two anti-parallel
helices (designated A and B) that pack against each other and
against neighbouring repeats to form an elongated solenoid [16].
In CRM1, the solenoid adopts a ring-like shape, with the A and B
helices defining the outer and inner surfaces, respectively. Ran
binds inside the ring, engaging the B helices of N- and C-terminal
HEAT repeats as well as a large loop within HEAT repeat 9 [15].
Spn1 binds to the outer surface of CRM1 through an extensive
interface involving HEAT repeats 11–16 and three regions of
Spn1: the N-terminal NES motif, the nucleotide-binding domain
and a C-terminal epitope. The NES motif adopts a helical
structure and occupies a hydrophobic groove formed by the A
helices of HEAT repeats 11 and 12 [14,15]. Details of cargo
recognition have been further elucidated by structures of CRM1
bound to PKI- and Rev-type NESs [17].
RanBP3 is a Ran-interacting protein with diverse roles in
nuclear transport. For example, RanBP3 associates with RCC1
and enhances its catalytic activity towards Ran [18,19], plays an
important role in linking the Ras/ERK/RSK and PI3K/Akt
signalling pathways to nuclear transport [20], and stimulates the
CRM1-independent nuclear export of b-catenin, Smad2 and
Smad3 [21,22]. However, RanBP3 is best known for its role as a
co-factor of CRM1-mediated export. Specifically, RanBP3
enhances the rate of NES export by increasing the affinity of
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cargo complex in the nucleus [23,24]. RanBP3 further promotes
export complex assembly by increasing the nucleoplasmic pool of
CRM1 [25] and by recruiting CRM1 to RCC1, where it facilitates
the association of CRM1 with RanGTP [19]. In the absence of
Ran and cargo, RanBP3 inhibits CRM1 from interacting with the
NPC, thereby reducing futile cycles of transport [24]. Finally,
RanBP3 modulates the substrate selectivity of CRM1, enhancing
its affinity for the HIV-1 Rev NES while decreasing that for Spn1
[23].
RanBP3 belongs to a class of Ran-binding proteins character-
ized by one or more Ran-binding domains (RBDs) of approxi-
mately 120 residues [18]. The RBD of RanBP3 is flanked by N-
and C-terminal regions that are predicted to be intrinsically
disordered (Figure 1). The N-terminal region contains a nuclear
localization signal (NLS) that is preferentially recognized by
importin a3 and is responsible for concentrating RanBP3 in the
nucleus [26]. The N-terminal region is also required for RanBP3
to bind CRM1, an interaction putatively mediated by two FxFG
motifs located between the NLS and the RBD [24]. Other RBD-
containing proteins include RanBP1, a cytosolic protein that
comprises little more than a single RBD [27,28], and RanBP2/
Nup358, a giant nucleoporin that localizes to the cytosolic face of
the NPC and contains four RBDs [29] (Figure 1). RanBP1 and
RanBP2 act as cofactors for RanGAP, enhancing the rate of GTP
hydrolysis on Ran by approximately an order of magnitude [30].
RanBP1 and RanBP2 also promote the disassembly of trimeric
CRM1/RanGTP/NES complexes in the cytosol [31–33]. This
activity has been rationalized by the recent crystal structure of
yeast CRM1 bound to RanGTP and RanBP1: RanBP1 induces a
conformational change in the Ran-interacting HEAT-9 loop of
CRM1, leading to constriction of the NES-binding groove and
consequent release of the NES [33]. RanBP1 also promotes
dissociation of CRM1 from nucleoporins located on the
cytoplasmic periphery of the NPC [12,31,34], allowing CRM1
to recycle to the nucleus for a new round of export.
Broadly speaking, all three of the above Ran-binding proteins
render CRM1-mediated export more efficient. However, whereas
RanBP1 and RanBP2 accelerate the terminal steps of export by
disassembling the export complex in the cytosol, RanBP3
enhances the initial stages of export by promoting assembly of
the CRM1/Ran/NES complex in the nucleus. Another difference
is that RanBP1 and RanBP2 bind tightly to RanGTP (with Kd
values for individual RBDs between 1.2 and 20.8 nM), whereas
RanBP3 binds relatively poorly (Kd,10 mM) [18,35,36]. This
presumably allows Ran-bound RanBP3 in the context of a
RanBP3/CRM1/Ran/NES complex to be efficiently displaced by
RanBP1 or by RanBP2 upon cytosolic entry of the export
complex.
To better understand the divergence in function among RBD-
containing proteins, we undertook a structural study of the
RanBP3 RBD. We determined the high-resolution crystal
structure of this domain and compared it to known RBD
structures from RanBP1 and RanBP2, previously determined in
complex with various binding partners. The analysis sheds light on
RanBP3 with regard to its weak Ran-binding activity, its influence
on the cargo-binding selectivity of CRM1, and its ability to
stabilize a CRM1/Ran/NES complex in the nucleus.
Results and Discussion
Structure of the RBD of RanBP3
Initial efforts to crystallize the RBD of RanBP3 in complex with
Ran were hampered by the weak Ran-binding affinity of this
domain, which we estimated by isothermal titration calorimetry
(ITC) to correspond to a Kd of 1460.3 mM (Figure 2; Figure S1
shows the corresponding experiment for full-length RanBP3), in
agreement with a previous semi-quantitative study [18]. We
therefore pursued the structure of the RBD in its unbound form.
We solved the structure at 1.61 A ˚ resolution using experimental
phases obtained from a platinum derivative, and at 2.1 A ˚ in a
second crystal form by molecular replacement. (Crystallographic
statistics are summarized in Table 1). As expected, the RanBP3
RBD adopts a pleckstrin homology fold, composed of 7 anti-
parallel b-strands and a C-terminal a-helix. The strands define a
continuous sheet with simple up-down topology, forming an
imperfect b barrel that juxtaposes strands 4 and 6 and extrudes
strand 5 (Figure 3A). The C-terminal helix caps the barrel, packing
against strands 1, 2, 5 and 6. The loops at the base of the barrel
and a shallow depression on the protein surface between the b1b2
and b5b6 loops (asterisk in Figure 3A and B) correspond to
important Ran-binding epitopes in known structures of Ran/RBD
complexes. Crystal forms 1 and 2 contain two and four molecules
per asymmetric unit, respectively, and aligning these structures
reveals variations in the N- and C-terminal residues and in several
loops, reflecting the inherent flexibility of these regions (Figure S2;
Table S1). In contrast, the b5b6 loop, whose functional role is
evoked below, is highly uniform in structure, suggesting a
comparatively rigid element. Our crystal structure of the RanBP3
RBD is consistent with an NMR structure determined by a
structural genomics consortium [37] (PDB code 2CRF), although
aligning the two structures yields a high rmsd value (1.6 A ˚ for 100
Ca residues, omitting variable regions), which we attribute to
coordinate errors in the NMR model.
Structures are known for human and yeast RanBP1 and for the
first and second RBD domains of RanBP2 (RanBP2-1 and
RanBP2-2) [33,38–40], all of which bind Ran with high affinity.
These domains share less than 25% sequence identity with the
RanBP3 RBD and when structurally aligned with our crystal
structure yield rmsd100 values [41] of 1.6–2.1 A ˚ (Table S2). This
Figure 1. Domain organization of Ran and of Ran-binding
proteins. Boundaries of the RBD domains and of Ran elements are
indicated. FG, FxFG motif; NLS, nuclear localization signal; CycHD,
cyclophilin homology domain; Gdom, G-domain. For clarity, the FG
repeats (over 20) of RanBP2 are not shown.
doi:10.1371/journal.pone.0017011.g001
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affinity RBDs (e.g., for RanBP1 versus RanBP2-1 the identity is
62% and rmsd100 is 0.89 A ˚). The most notable differences are the
positioning of the C-terminal helix relative to the b barrel and the
conformation of four loop regions (Figure 3B and Figure S3). In
particular, the b5b6 loop in RanBP3 (res. 401–404) is two residues
shorter than in the high-affinity RBDs, forming a type I b turn
rather than a loop. The high affinity RBDs all possess a bulky
aromatic residue (Trp120 in RanBP1) at the base of this loop,
causing the latter to project outwards as a prominent protrusion on
the protein surface (Figure S4A and B). In contrast, RanBP3 has a
smaller (Ile405) residue here, which together with the shortened
loop results in a smoother profile. As a result, the RanBP3 exhibits
a surface depression that is markedly less pronounced than in the
high-affinity RBDs (Figure S4B), which recognize the Ran C-helix
through this feature.
Structural basis of weak Ran binding
Structures of a Ran-bound RBD have been determined in the
context of three different complexes: the RanBP2-1/Ran,
RanBP1/Ran/RanGAP and Yrb1/Ran/CRM1 complexes
(Yrb1 is yeast RanBP1) [33,38,39]. The Ran-RBD interface is
essentially identical in all these structures, as residues mediating
Ran recognition are highly conserved across the three RBDs
(Figure 3C) and because the interface is unaffected by either
CRM1 or RanGAP binding. The Ran-RBD interaction has been
described as a ‘‘molecular embrace’’ [38], in which Ran wraps its
C-terminal tail around the RBD, and the RBD wraps its N-
terminal extension around Ran (Figure 4A). The intermolecular
contacts thus fall into three classes: those between the RBD N-
terminal extension and the globular Ran guanine-nucleotide
binding domain (G domain) (class 1); those between the Ran C-
terminal tail and the RBD globular domain (class 2); and those
between the two globular domains (class 3). Class 1 contacts are
mediated by 8 residues in the RBD N-terminal extension, of which
5 make van der Waals contacts and 3 make H bonds via main
chain atoms (Figure 3C). Class 2 contacts involve all three moieties
of the Ran C-terminal tail (linker, C-helix, DEDDDL motif) and
comprise: H bonds between the Ran linker and RBD strands b3
and b4, van der Waals contacts between the Ran C-helix and the
RBD surface depression (asterisk in Figure 3B), and electrostatic
interactions between the DEDDDL motif and basic RBD residues.
Class 3 includes salt bridge interactions between the EWKER
motif in RBD strand b2 and the nucleotide-binding effector loop
of Ran.
To understand why RanBP3 binds RanGTP with such low
affinity, we modelled a RanBP3-RBD/Ran complex by superim-
posing our RBD crystal structure onto that of the RanBP2-1/Ran
complex and by altering the side chains of the RanBP2-1 N-
terminal extension to match the RanBP3 sequence. Intermolecular
contacts from all three classes are either absent or are partly
compromised in this model. First, the HFEPVV motif within the
N-terminal extension of high-affinity RBDs is poorly conserved in
RanBP3, which lacks the three residues (underlined) that mediate
hydrophobic contacts with Ran (Figure 3C). Second, substitutions
within the EWKER motif (RanBP3 residues
49SWVER) are
predicted to disrupt salt bridge interactions with the Ran effector
loop (Figure 4B). Third, the substitution of charged residues by
Gly and Ser residues at positions 381 and 423 is predicted to
disrupt hydrogen bonds with the Ran G-domain and DEDDDL
motif, respectively (Figure 4C and D). Finally, four of the five
RanBP2-1 residues that make van der Waals contacts with the
Ran C-helix are not conserved in RanBP3 (Figure 3C). All
together, nearly half of the intermolecular interactions observed in
Figure 2. ITC profile of Ran binding by RanBP3 RBD. Differential
power (DP) time course of raw injection heats for a titration of 800 mM
RanBP3 RBD (residues 310–454) into 70 mM RanQ69L:GTP. The binding
reaction and the heat of dilution have different signs. RanQ69L is a
mutant form of Ran compromised for intrinsic GTPase activity [8], used
to stabilize the active GTP-bound form of Ran over the time course of
the experiment. The inset shows normalized binding enthalpies
corrected for the heat of dilution as a function of binding site
saturation. The solid line represents a nonlinear least squares fit using a
single-site binding model. Kd,obs was 1460.3 mM and the stoichiometry
was 0.9360.01.
doi:10.1371/journal.pone.0017011.g002
Table 1. Crystallographic data collection and refinement
statistics.
Form 1 Form 2
Data collection:
Space group P3121 P212121
Unit cell dimensions (A ˚) a=b=61.3, c=137.2 a=62.9, b=73.4,
c=120.4
Resolution range (A ˚) 35-1.61 (1.70 - 1.61) 48-2.1 (2.21 - 2.1)
ESRF Beamline ID23-1 ID14-4
Wavelength (A ˚) 1.0723 0.9795
No. unique reflections 37445 (4741) 33296 (4766)
Rsymm (%) 5.6 (53.4) 6.3 (38.4)
I/s(I) 26.7 (4.3) 19.8 (4.8)
Completeness (%) 94.7 (81.1) 100 (100)
Multiplicity 10.7 (9.2) 5.6 (5.7)
Refinement:
Monomers /ASU 2 4
No. protein atoms 1864 3789
No. water molecules 299 246
Rwork/Rfree 0.147 / 0.196 0.193 / 0.225
Rmsd bonds (A ˚) 0.005 0.003
Rmsd angles (u) 0.890 0.756
Ramachandran Plot:
Most favoured (%) 94.5 93.3
Allowed (%) 5.5 6.5
Generously allowed (%) 0 0.2
Outliers 0 0
Molprobity Score 1.67 (77
th percentile) 2.11 (73
rd percentile)
doi:10.1371/journal.pone.0017011.t001
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RanBP3-RBD model, sufficiently accounting for the poor affinity
observed.
Interestingly, the intermolecular contacts predicted to be
conserved in our model are not distributed in a random manner.
This is readily seen by comparing the RBD surface contacted by
Ran with the surface conserved between RanBP3-RBD and
RanBP2-1 (Figure 4E). Whereas the RBD surface regions that
interact with the Ran G-domain and linker are well conserved,
those that contact the C-helix are not. This, and the predicted loss
of a H-bond to the DEDDDL-motif (Figure 4C), suggests that the
Ran C-terminal tail may wrap less stably around the RanBP3
RBD, or that the path of the C-helix and DEDDDL motif along
the RanBP3 RBD surface may differ significantly from that
observed for the high-affinity RBDs. This is similar to a recent
conjecture (based on differences in electrostatic potential of the
Figure 3. Structure of the RanBP3 RBD. A. Ribbon diagram. The asterisk indicates the surface depression which in homologous RBD structures
accommodates the Ran C-helix. B. Structural alignment of the RanBP3 RBD (magenta) with RanBP1 (green). C. Sequence alignment of RBDs of known
structure. The b5b6 loop is boxed. Residues in lower case are missing from the structures. RanBP2-1 residues that contact Ran are marked by a circle,
triangle or square according to the type of contact (van der Waals, H-bond mediated by a side chain, or H-bond mediated by backbone, respectively)
[38]. Marks are coloured according to whether the Ran residue contacted lies in the G-domain (black), effector loop (green), linker (magenta), C-helix
(blue) or DEDDDL motif (open triangle).
doi:10.1371/journal.pone.0017011.g003
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more weakly than RanBP1 [33].
Insights into cofactor activity
RanBP3 alters the cargo-binding selectivity of CRM1, favouring
the binding of NES-bearing peptides over that of Spn1 [23]. How
does this occur? Aligning our model of a RanBP3-RBD/Ran
complex onto the CRM1/Ran/Spn1 structure reveals a severe
steric clash between the RanBP3 RBD and Spn1 (Figure 5). The
clash involves two regions of the nucleotide-binding domain of
Spn1: helix a4, which overlaps with strand b1 of the RBD, and
strands b4 and b5, which overlap with the RBD C-terminal helix.
In contrast, neither the N-terminal NES nor the C-terminal
CRM1-binding epitope of Spn1 are involved in the clash. This
Figure 4. Structural basis of weak Ran-binding. A. Structural alignment of the RanBP3 RBD with the RanBP2-RBD1/Ran complex. Ribbon
diagrams show Ran (green), RanBP2-1 (blue) and RanBP3 (magenta). The GTP analog GppNHp is in navy blue. B–D. Details of the interface. The
carbon atoms of RanBP2-1 and RanBP3 residues are shown in green and magenta, respectively. B. The GluRSer and LysRVal substitutions within the
1154EWKER/
349SWVER motif are predicted to disrupt two salt bridge interactions between Ran and the RBD. C, D. The R1284/S423 (C) and Q1248/
G381 (D) substitutions are predicted to disrupt interactions with the Ran
211DEDDDL motif and with Glu158 in the G-domain, respectively. E. RBD
surface plots. The two left-hand panels are related to (A) by an approximately 180u rotation about the vertical axis. Top, RanBP2-1 residues within 4 A ˚
of Ran are coloured blue. Bottom, RanBP3 residues identical to RanBP2-1 are coloured magenta. The conserved and contact surfaces are similar in the
vicinity of the Ran G-domain and linker (left panels), but not near the Ran C-helix (right panels).
doi:10.1371/journal.pone.0017011.g004
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inhibiting the nucleotide-binding domain from stably associating
with CRM1, leaving only the NES motif and C-terminal epitope
to interact. The isolated NES of Spn1 is known to have lower
affinity for CRM1 than canonical NESs such as those in PKI or
Rev [17]. Hence, inhibiting the nucleotide-binding domain from
interacting with CRM1 would allow canonical NES-bearing
peptides to compete with Spn1 more effectively, explaining why
RanBP3 increases the selectivity of CRM1 towards such cargos
relative to Spn1 [23]. More generally, at a distance of ,30 A ˚ from
the NES-binding groove, the RanBP3 RBD is well positioned to
influence the cargo selectivity of CRM1 by interacting with (or
excluding) cargo moieties that occupy volumes adjacent to (or
overlapping with) that occupied by the RBD on the CRM1
surface.
Unlike RanBP1 and RanBP2, which disassemble CRM1 export
complexes, RanBP3 stabilizes the latter by increasing the affinity
of CRM1 for RanGTP. To understand how this difference arises,
we aligned the structures of the RanBP3 RBD and of CRM1 from
the CRM1/Ran/Spn1 complex [15] onto the structure of the
CRM1/Ran/RanBP1 complex [33] (Figure 6A). RanBP1 disas-
sembles export complexes by causing the Ran-interacting HEAT-
9 loop to switch from an ‘‘outward’’ conformation that promotes
favourable interactions with Ran (red loop in Figure 6A) to an
‘‘inward’’ conformation (blue loop) that induces a constriction of
the NES-binding groove and consequent NES release [33].
RanBP1 accomplishes this by both destabilizing the outward
and stabilizing the inward conformations. It destabilizes the
outward conformation by positioning the Ran C-terminal
DEDDDL motif so as to cause steric and electrostatic repulsion
with the HEAT-9 loop (Figure 6B). The protrusion on the
RanBP1 surface formed by the b5b6 loop plays an important role
here, as it guides the DEDDDL motif into position. In contrast,
this protrusion is missing from the RanBP3 RBD (Figure S4B),
which, as discussed above, likely binds the Ran C-helix and
DEDDDL motif more weakly than RanBP1 and/or positions
these elements differently.
Conversely, RanBP1 stabilizes the HEAT-9 loop in its inward
conformation through interactions mediated by three basic residues
located in RanBP1 strand 1 and in the b3b4 loop. RanBP1 residues
Lys88 and Lys130 make salt bridge interactions with three acidic
residues in the HEAT-9 loop (Asp436, Glu437 and Glu439), while
RanBP1 residue Arg90 participates in a cation-pi interaction with
loop residue Phe444 (Figure 6C). None of these interactions would be
conserved in a RanBP3/CRM1 complex, as the three basic RanBP1
residues are replaced in RanBP3 by a glycine and two glutamine
residues. In short, RanBP1 destabilizes the outward HEAT-9 loop
conformation and favours the inward conformation, whereas the
RanBP3 RBD appears poorly suited for stabilizing the inward, but
compatible with the outward, conformation. These differences
rationalize why RanBP1 disassembles CRM1 export complexes
w h e r e a sR a n B P 3d o e sn o t .
How then does RanBP3 increase the affinity of CRM1 towards
Ran? Our structural alignment suggests that the RanBP3 RBD
could feasibly stabilize the HEAT-9 loop in its outward
conformation, as residues in strand 1 and in the b5b6 turn are
well placed to interact favourably with residues in the HEAT-9
loop. These include RanBP3 residues Lys339 and Lys403, which
could potentially form salt bridge interactions with CRM1 residue
Glu434 (Figure 6B). As has been previously noted [42], stabilizing
the outward HEAT-9 loop conformation is an obvious way by
which RanBP3 could increase the affinity of CRM1 for Ran.
Admittedly, however, such a role for the RBD would provide at
best only a partial explanation of how RanBP3 functions, as it
ignores the contribution of the FxFG-containing region known to
mediate CRM1 binding and to be crucial for cofactor activity
[24]. It is tempting to speculate that the binding of this region to
CRM1 destabilizes the inward conformation of the HEAT-9 loop,
allowing for the latter to be subsequently stabilized in its outward
conformation by the RBD. However, fully elucidating the
mechanism by which RanBP3 increases the Ran-binding affinity
of CRM1 will require further study, including the structure
determination of a CRM1/RanBP3 complex.
Concluding remarks
The five RBDs of RanBP1 and RanBP2 are phylogenetically
closely related, whereas the RBD of RanBP3 diverges considerably
from these. One might therefore reasonably expect a detailed
comparison of the divergent RBD structures to yield a better
understanding of the strikingly different roles performed by the
corresponding proteins in CRM1-mediated export. Indeed, the
structural analysis presented above offers highly plausible explana-
tions for why RanBP3 binds Ran more weakly than RanBP1 and
RanBP2, how RanBP3 modulates the cargo selectivity of CRM1,
Figure 5. Steric clash between the RanBP3 RBD and Spn1. A. The Ran/RanBP3-RBD model was aligned with the CRM1/Ran/Spn1 crystal
structure [15]. CRM1 is coloured from N- to C-terminus as a rainbow from red to white to blue. The nucleotide binding domain of Spn1 is in yellow,
while the NES is in red; the asterisk indicates the C-terminal CRM1-binding epitope of Spn1. B. Stereoview of the region of steric overlap.
doi:10.1371/journal.pone.0017011.g005
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PLoS ONE | www.plosone.org 6 February 2011 | Volume 6 | Issue 2 | e17011Figure 6. Structure of the CRM1/Ran/RanBP1 complex and alignment with RanBP3 RBD. A. Murine CRM1 from the CRM1/Ran/Spn1
complex [15] was aligned with yeast CRM1 from the CRM1/Ran/ RanBP1 complex [33] by superimposing the B helices of HEAT repeats 9–17; RanBP3
RBD was superimposed onto RanBP1. For clarity, only the HEAT-9 loop of murine CRM1 is shown (in red; that of yeast CRM1 is in blue). Yeast CRM1 is
coloured from N- to C-terminus as a rainbow from red to white to blue. The large and small boxes indicate regions viewed in B and C, respectively. B.
Close-up stereoview of the Ran C-terminal region. The DEDDDL motif of Ran (yellow) overlaps sterically with the outward conformation of the HEAT-9
loop (red). The black star indicates the b5b6 loop of the RBD, which is shorter in RanBP3 than in RanBP1. Favourable interactions are predicted
between RanBP3 residues Lys339 and Lys403 and acidic residues in the HEAT-9 loop. For clarity, Ran residues 211–214 are labelled a–d and the G-
Structure of the RanBP3 RBD
PLoS ONE | www.plosone.org 7 February 2011 | Volume 6 | Issue 2 | e17011and why RanBP3 fails to disassemble export complexes. In addition,
it provides clues into how RanBP3 increases the Ran-binding affinity
of CRM1 in the nucleus. Fully unravelling this last question remains
an important challenge for future study.
Materials and Methods
Protein expression and purification
Human full-length RanBP3 (residues 1–499; isoform B) and two
RanBP3 RBD constructs (residues 310–454 for ITC and residues
320–454 for crystallization) were cloned in a pETM11 vector as
fusion constructs containing an N-terminal His tag and a TEV
protease cleavage site. Transformed E. coli strain BL21 (DE3) Gold
(Stratagene) cells were grown in LB medium containing kanamy-
cin (50 mg/mL) until reaching an OD600 of 0.8, induced with
0.5 mM isopropyl b-D-thiogalactoside (IPTG) and incubated for a
further 3 h at 37u before harvesting. Cells were lysed by sonication
in 20 mM Tris pH 8, 200 mM NaCl, 5 mM imidazole, 1 mM b-
mercaptoethanol, 1 mM PMSF and Complete protease inhibitor
EDTA-free (1 tablet/50 ml; Roche). The clarified lysate was
incubated with Ni-NTA resin (Qiagen) and washed with buffer A
(20 mM Tris pH 8, 150 mM NaCl, 10 mM imidazole, 1 mM b-
mercaptoethanol, 1 mM PMSF). Proteins were eluted with
250 mM imidazole, dialysed overnight in the presence of His-
tagged TEV protease against buffer A containing no imidazole,
and incubated with Ni-NTA resin to remove His-tag containing
species. Proteins were further purified on a Superdex 75 column
(GE Healthcare) in 20 mM Tris pH 8, 100 mM NaCl and 1 mM
DTT and concentrated on a Centricon centrifugal filtration device
(Millipore).
Full-length human Ran containing the Q69L mutation was
expressed from a pPROEx vector as an N-terminally His-tagged
protein containing a TEV protease site. Transformed E. coli BL21
(DE3) CodonPlus RILP (Stratagene) cells were grown in TB
medium containing ampicillin (100 mg/ml) and chloramphenicol
(30 mg/ml) until reaching an OD600 of 0.8, induced with 0.5 mM
IPTG and incubated overnight at 18uC before harvesting. Cells
were lysed in buffer B (30 mM Tris pH 7.4, 180 mM NaCl,
10 mM imidazole pH 7.4, 5 mM MgCl2,2m Mb-mercaptoeth-
anol, Complete protease inhibitor EDTA-free (1 tablet/50 mL;
Roche)) containing DNase I (10 mg/mL) and lysozyme (1 mg/mL)
using a French Press. The clarified lysate was loaded onto a
HisTrap column (GE Healthcare) and Ran was eluted with an
imidazole gradient (0–400 mM). The protein was dialysed
overnight in the presence of His-tagged TEV protease against
buffer B containing 0 mM imidazole plus 10% glycerol, and
subsequently passed over a second HisTrap column to remove
His-tag containing species. Ran was then applied to a MonoQ HR
5/5 column (GE Healthcare) pre-equilibrated in 50 mM Tris
pH 7.4, 5 mM MgCl and 2 mM DTT, and purified protein was
recovered in the flow-through. The protein was concentrated by
using a HiTrap SP (GE Healthcare) column pre-equilibrated in
20 mM Tris pH 7.4, 5 mM MgCl2, 5 mM DTT and eluting with
a NaCl gradient (0–1.5 M). RanQ69L was loaded with GTP by
incubating with a 300-fold molar excess of GTP in the presence of
10 mM EDTA at 4uC for 1 hour and then at 20uC for an
additional 1–2 hours, followed by addition of 15 mM MgCl2 to
halt the nucleotide exchange reaction. The protein was separated
from unbound nucleotides by Superdex 75 (GE Healthcare)
chromatography in 10 mM Tris pH 7.5, 70 mM NaCl, 5 mM
MgCl2 and 1 mM DTE. HPLC analysis confirmed that RanQ69L
was fully charged with GTP.
Isothermal Titration Calorimetry
ITC was carried out at 25uC using a VP-ITC Microcal
calorimeter (Microcal, Northhampton, MA, USA). All proteins
were freshly purified and dialysed extensively against ITC buffer
(300 mM NaCl, 5 mM MgCl2, 10 mM TRIS pH 7.4) prior to ITC
measurements. Titrations consisted of 6–12 mL aliquot injections
made at time intervals of 5 min to ensure that the titration peak
returnedtothebaseline.TheITCdatawereanalyzedand corrected
for the heat of dilution of injectant into buffer using program Origin
version 5.0 provided by the manufacturer.
Structure determination
The RanBP3 RBD was crystallized by hanging drop vapour
diffusion at 20uC by mixing 12 mg/mL (crystal form 1) or 20 mg/
mL (crystal form 2) protein with an equal volume of crystallization
buffer. Crystal form 1 grew from 1.5 M Li2SO4, 100 mM Hepes
pH 7.5, and form 2 grew from 30% PEG 3350, 50 mM TRIS
pH 8.5. All crystals were cryo-protected in 30% glycerol. Diffraction
data were processed using XDS [43] or MOSFLM [44] and
programs of the CCP4 suite [45]. The structure of crystal form 1 was
determined by the SIRAS method, as attempts to solve the structure
by molecular replacement using the available NMR structure (PDB
id 2CRF) failed. Diffraction data were collected at 2 A ˚ resolution
from a crystal soaked for 3 hours in 2 mM K2PtCl4 and at 1.6 A ˚
resolution from a native crystal on ESRF beamline ID23-1
(l=1.0723 A ˚). Three Pt sites were located and phases calculated
usingprogramsSHELXDandSHELXE[46].Theresultingelectron
density map was almost entirely autotraced by ARP/wARP [47],
with the remainder traced manually in COOT [48]. The final
structure was refined against the native data (Rcryst=14.7%,
Rfree=19.6%) using program Phenix [49]. (Hydrogen atoms were
not included in the refinement). Diffraction data from crystal form 2
were collected at 2.1 A ˚ resolution at ESRF beamline ID14-4
(l=0.9795 A ˚). The structure was solved by molecular replacement
using program PHASER [50] and refined to an R-value of 19.3%
(Rfree=22.5%) and good geometry (Table 1). Structures were
determined for both the wildtype protein and a double point mutant
(E352A/R352V) compromised for Ran binding [23]. These
structures are identical except for the side chains at the mutated
positions. Figures were made with Pymol (DeLano scientific LLC,
San Carlos, CA, USA, http://www.pymol.org).
Accession numbers
Coordinates and structure factors for the wildtype and E352A/
R352V mutant of the RanBP3 RBD have been deposited in the
Protein Data Bank (PDB) under the accession codes 2Y8F and
2Y8G, respectively.
Supporting Information
Figure S1 ITC profile of Ran binding by full-length
RanBP3. Differential power (DP) time course of raw injection heats
for a titration of 530 mM RanQ69L:GTP into 48 mMR a n B P 3 .T h e
domain is not shown. C. Close-up stereoview of the inward HEAT-9 loop conformation (blue). Double arrows indicate cation-pi and electrostatic
interactions. In (B) and (C), CRM1 and Ran residues are labelled according to the human/murine numbering. (Human CRM1 residues 434–444 and Ran
residues 211–214 correspond to yeast CRM1 residues 445–455 and Ran residues 213–216, respectively). RanBP1 residues follow the yeast numbering.
All RanBP1 and CRM1 residues shown in (C) are conserved between yeast and human.
doi:10.1371/journal.pone.0017011.g006
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dilution as a function of binding site saturation. The solid line
represents a nonlinear least squares fit using a single-site binding
model. Kd,obs was 1563 mM and the stoichiometry was 0.7860.06.
The shape of the curve suggests the presence of additional processes
(not observed with the isolated RBD; Figure 2) having different
kinetics than the dilution and binding reactions. This conceivably
may be due to residues within the intrinsically disordered N-terminal
domain of RanBP3 changing conformation in the presence of Ran.
(TIF)
Figure S2 Alignment of RanBP3 RBD molecules. The two
molecules (1A and B) in the asymmetric unit of crystal form 1 and
the four (2A–D) from crystal form 2 were structurally aligned and
are shown as a Ca trace in stereoview. The b2b3 loop is
disordered in molecules 2B, 2C and 2D, while the b6b7 loop is
disordered in molecules 1A and 1B. The N-terminal 10 residues
are disordered in all molecules except 2A and 2D. In molecule 2A,
these residues fold back to pack loosely against strands b2 and b3;
in molecule 2D, the N-terminal residues include a small a helix
(res. 322–327; asterisk) and extend outward to interact with 3
neighbouring molecules in the crystal lattice.
(TIF)
Figure S3 Alignment of RBD structures shown as a
stereo Ca trace. The structures of RanBP1 [39], RanBP2-1
[38], RanBP2-2 [40] and Yrb1 [33] (corresponding to PDB entires
1K5G, 1RRP, 1XKE and 3M1I, respectively) were aligned onto
the RanBP3 RBD structure.
(TIF)
Figure S4 Structural differences in the b5b6 loop. A.
Structural alignment of RanBP3-RBD (magenta) with RanBP1
(green). The view is that of Figure 2B, right panel. Inset: Stereoview of
the b5b6 loop. Residues in RanBP1 and RanBP3 are shown with
carbon atoms coloured green and magenta, respectively. B. Surface
representation of the RBD from RanBP3 and RanBP1 and of the
secondRBDofRanBP2.Theasteriskindicatesthesurfacedepression
that recognizesthe RanC-helix, which is markedlymorepronounced
in RanBP1 and RanBP2-1 than in the RanBP3 RBD. The surface
corresponding to the b5b6 loop is coloured more darkly.
(TIF)
Figure S5 Comparison of RBD surfaces. A. Ribbon
diagram of the RanBP1/Ran complex [39]. Side chains are
shown for acidic residues within the C-terminal
211DEDDDL
motif of Ran. B. Electrostatic surface plots of RanBP1, RanBP2-1
[38] and the RanBP3 RBD, with the Ran C-terminal tail from the
RanBP1/Ran complex superposed to facilitate comparison. The
regions indicated by an oval show that the RanBP3 RBD has a
distinctly less basic character in the vicinity of the DEDDDL motif
than the other two RBDs, as previously pointed out [33]. The
figure was prepared using program CCP4MG and is coloured
from 20.5 V (red) to +0.5 V (blue).
(TIF)
Table S1 Comparison of RanBP3 RBD molecules in the
two crystal forms. *R m s dv a l u e sb e l o wt h ed i a g o n a la r ef o r
pairwise alignments made using all Ca atoms; subscripts indicate the
number of Ca atoms aligned (these vary between 108 and 121
because the residues that are disordered vary among molecules).
Values above the diagonal are for alignments made using a common
core of 93 Caatoms (residues 330–343, 350–363, 373–409, 418–446;
i.e. excluding the N- and C-termini and variable loops). { rmsd100 is
the normalized rmsd value of Carugo and Pongor [42], which allows
one to compare two or more rmsd values calculated from alignments
made using different numbers of Ca residues: rmsd100=rmsd/{1+ln
[ (N/100)
K ]}. Pairwise alignments of the six structures yield a mean
rmsd100 value of 1.51 A ˚, primarily reflecting variations in the N- and
C-terminal regions and in the b1b2, b2b3a n db6b7 loops. Excluding
these regions yields a much lower value (0.64 A ˚), indicating that the
core structure is highly conserved.
(DOC)
Table S2 Comparison of RBD structures. { Structures
were aligned against RanBP3 residues 330–446 and rmsd values
were calculated for all equivalent (between 97 and 116) Ca
positions. Pairwise alignments were made between all six molecules
of the RanBP3-RBD structure (1A–B, 2A–2D) and all chains in the
X-ray structures (1K5G: 4 chains, 1RRP 2 chains, 3MI1, 1 chain);
for NMR structure 1XKE the 1
st,1 0
th,a n d2 0
th models in the PDB
file were used. Values were then converted to rmsd100 scores (see
Table S1) and averaged. * Pairwise structural alignments involving
RanBP1, RanBP2-1, RanBP2-2 and Yrb1 (multiple chains for each
structure) yielded between 99 and 134 topologically equivalent Ca
positions. The resulting rmsd values were converted to rmsd100
scoresand averaged.AlignmentsinvolvingRanBP2-2systematically
give higher rmsd values because of greater coordinate errors in the
NMR model compared to the high-resolution crystal structures.
(DOC)
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